Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trialFernanda Palhano-Fontes, Dráulio Barros de Araújo, Heloisa Onias et al.|Psychological Medicine|2018Cited by 819
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary reportFlávia de Lima Osório, Jaime E. C. Hallak, Dráulio Barros de Araújo et al.|Brazilian Journal of Psychiatry|2015Cited by 484
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent DepressionRafael Faria Sanches, Jaime E. C. Hallak, Jordi Riba et al.|Journal of Clinical Psychopharmacology|2015Cited by 465
Clinical validity and intrarater and test–retest reliability of the Structured Clinical Interview for DSM‐5 – Clinician Version (SCID‐5‐CV)Flávia de Lima Osório, José Alexandre S. Crippa, Rafael Faria Sanches et al.|Psychiatry and Clinical Neurosciences|2019Cited by 338
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 yearsRafael G. dos Santos, Jaime E. C. Hallak, Flávia de Lima Osório et al.|Therapeutic Advances in Psychopharmacology|2016Cited by 303